[Federal Register Volume 59, Number 208 (Friday, October 28, 1994)]
[Unknown Section]
[Page ]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-26709]
[Federal Register: October 28, 1994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CRADA NIO-95-001]
National Institute for Occupational Safety and Health;
Cooperative Research and Development Agreement
AGENCY: Centers for Disease Control and Prevention (CDC), Public Health
Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), National
Institute for Occupational Safety and Health (NIOSH), announces the
opportunity for potential collaborators to enter into a Cooperative
Research and Development Agreement (CRADA) to develop a system or
systems to automate sampling method development and analysis for
airborne contaminants.
It is anticipated that all inventions which may arise from this
CRADA will be jointly owned. The collaborator(s) with whom the CRADA is
made will have an option to negotiate an exclusive or non-exclusive
royalty-bearing license. The CRADA will be executed for a 2-year period
with the possibility of renewal for another 2-year period.
Because CRADAs are designed to facilitate the development of
scientific and technological knowledge into useful, marketable
products, a great deal of freedom is given to Federal agencies in
implementing collaborative research. The CDC may accept staff,
facilities, equipment, supplies, and money from the other participants
in a CRADA; CDC may provide staff, facilities, equipment, and supplies
to the project. There is a single restriction in this exchange: CDC MAY
NOT PROVIDE FUNDS to the other participants in a CRADA. This
opportunity is available until 30 days after publication of this
notice. Respondents may be provided a longer period of time to furnish
additional information if CDC finds this necessary.
FOR FURTHER INFORMATION CONTACT: Technical: Eugene R. Kennedy, Ph.D.,
Methods Development Section 2, Methods Research Branch, Division of
Physical Sciences and Engineering, NIOSH, CDC, 4676 Columbia Parkway,
Mailstop R-7, Cincinnati, Ohio 45226, telephone, (513) 841-4392, FAX
(513) 841-4500.
Business: Theodore F. Schoenborn, Technology Transfer Coordinator,
NIOSH, CDC, 4676 Columbia Parkway, Mailstop R-2, Cincinnati, Ohio
45226, telephone, (513) 841-4305, FAX (513) 841-4500.
SUPPLEMENTARY INFORMATION: The system or systems to be developed will
combine laboratory automation, with novel sampler designs and
analytical methodology to provide for an automated approach to method
development and evaluation. The collaborator(s) and NIOSH will jointly
perform the research aimed at development of a commercial system to
provide convenient sampling and analytical methods for airborne
contaminants. NIOSH will provide technical expertise, consultation and
guidance, verification of system integrity, and product evaluation and
testing. Since this CRADA involves the bringing together of diverse
technologies, a consortium of collaborators will be considered.
Applicants will be judged according to the following criteria:
1. Adequacy and technical capabilities to develop the desired
technologies and product;
2. Ability to develop, produce, market, and support system(s);
3. Evidence of technical credibility; and
4. Ability to complete the CRADA in a timely fashion.
This CRADA is proposed and implemented under the 1986 Federal
Technology Transfer Act: Public Law 99-502.
The responses must be made to: Theodore F. Schoenborn, Technology
Transfer Coordinator, National Institute for Occupational Safety and
Health, CDC, 4676 Columbia Parkway, Mailstop R-2, Cincinnati, Ohio
45226.
Dated: October 24, 1994.
Richard A. Lemen,
Acting Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention (CDC).
[FR Doc. 94-26709 Filed 10-27-94; 8:45 am]
BILLING CODE 4163-19-P
